American multinational health insurer and services group
PepsiCo has reported a mixed second quarter, with North American volumes flat or down and international markets driving overall growth. Revenue rose 6.4% to $24.18 billion, but North American beverage volumes fell 4% and per-share earnings narrowly missed expectations. The company has signaled a slower but steady recovery in North America as inflation pressures persist.
CVS Health has raised its 2026 guidance, citing stronger profits from its insurance and retail pharmacy segments and a marked improvement in its Aetna unit. The company is expanding GLP-1 weight-loss access through MinuteClinic, while flagging higher medical costs and macro risks.
Mangione has pleaded not guilty to state charges related to the 2024 killing of UnitedHealthcare CEO Brian Thompson. Jury selection is scheduled to begin Sept. 8, with an overflow courtroom planned for media and public access as debates over anonymity, evidence, and trial logistics intensify.
Lawyers and federal prosecutors have scheduled a Friday hearing after reports that Luigi Mangione is expected to plead guilty in the federal stalking case tied to the December 2024 killing of UnitedHealthcare CEO Brian Thompson. The plea would cover federal stalking counts that carry life sentences and will prompt legal fights over whether New York state murder charges can proceed.
Mangione has pleaded guilty in a federal case accusing him of stalking and killing UnitedHealthcare CEO Brian Thompson in 2024. A state murder trial is set for September 8, while the federal case could lead to a life sentence. Prosecutors say a large trove of evidence supports the guilt, including surveillance video and a 3D-printed pistol.
Prosecutors argue that the state and federal cases against Luigi Mangione involve different elements, while his attorneys contend the two prosecutions amount to double jeopardy. A ruling is expected in late autumn on whether his state murder and weapons charges proceed in New York.
UnitedHealth has raised its 2026 adjusted earnings outlook to at least $20.50 per share after a strong Q3, driven by value-based care and an expanding Optum Health turnaround. Analysts anticipate higher 2027 EPS as management views consensus targets as conservative. Meta Platforms’ Muse AI momentum is also shaping investor sentiment ahead of its Q3 results.